Clinical trials for Pancreas cancer

159 currently recruiting clinical trials

Phase 1 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06533059 #2024-515391-12-00
Locally Advanced Metastatic AKT 1 2 3 or more
BRAF KRAS G12C KRAS non G12C NRAS HRAS KRAS G12D Systemic Treatment-Naive
4 recruiting sites
Alterome Therapeutics, Inc.
Phase 1 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05216432
Locally Advanced Metastatic PIK3CA 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Relay Therapeutics, Inc.
Phase 1 Breast cancer Lung cancer Colon cancer Rectal cancer Pancreas cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06400472 #2024-511238-11-00
NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) HER2 Negative HR Negative 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Eli Lilly et compagnie
Phase 1 Breast cancer Lung cancer Colon cancer Rectal cancer Pancreas cancer #NCT06562192 #2023-510356-23-00
NSCLC (Non-Small Cell Lung Cancer) Adenocarcinoma HER2 Negative HR Negative HR Positive Locally Advanced Metastatic 1 2 3 or more Immunotherapy Chemotherapy Targeted therapy
Systemic Treatment-Naive
2 recruiting sites
Novartis
Phase 1 Lung cancer Colon cancer Rectal cancer Pancreas cancer #NCT06026410
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12C 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Kura Oncologie, Inc.
Phase 1 Pancreas cancer Stomach and esophageal cancer #NCT06005493 #2023-504139-42-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
2 recruiting sites
AstraZeneca
Phase 1 Lung cancer Colon cancer Rectal cancer Pancreas cancer #NCT06026410
NSCLC (Non-Small Cell Lung Cancer) Adenocarcinoma Locally Advanced Metastatic KRAS G12C 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Kura Oncologie, Inc.